On February 3, 2026, HP Inc. announced that Bruce Broussard, a board member since 2021 and former CEO of Humana Inc., has been appointed Interim Chief Executive Officer effective immediately. Broussard brings more than 30 years of executive leadership, including ten years as Humana’s CEO and senior roles at US Oncology. The Board has formed a CEO Search Committee and retained a global executive search firm to identify a permanent successor. This move is designed to ensure strategic continuity as HP advances its plan to lead the Future of Work through AI-powered devices, services and subscription offerings.

HP Inc.’s shares currently trade at approximately 6.4x forward price-to-earnings, near decade-cycle lows, with a dividend yield of 6.1%. These metrics contrast with normalized enterprise value/EBIT and EV/Sales multiples at multi-year troughs. A discounted cash flow analysis implies a fair value 30% above current levels, supported by resilient free cash flow generation exceeding $2.8 billion annually and manageable net leverage below 2.0x EBITDA. Investors focused on value and income may find HP’s disciplined capital return program—including sustainable dividends and opportunistic share repurchases—particularly compelling.

HP has reaffirmed its fiscal 2026 outlook, projecting GAAP diluted EPS of $2.47 to $2.77 and non-GAAP diluted EPS of $2.90 to $3.20. For the first quarter, the company expects GAAP EPS of $0.58 to $0.66 and non-GAAP EPS of $0.73 to $0.81, excluding approximately $0.15 per share of restructuring, acquisition and amortization charges. Free cash flow generation is forecast in the range of $2.8 to $3.0 billion for the full year. These stable targets reflect disciplined execution despite trade-related cost pressures and position HP to fund both its dividend and continued investment in AI-enabled PCs and industrial graphics solutions.